NCT02302235View on ClinicalTrials.gov

Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

May 31, 2022

Conditions
Glioblastoma Multiforme of Brain
Interventions
OTHER

Ketogenic Diet

Treatment will consist of ketogenic diet. KD will consist of 4:1 \[fat\] : \[protein+carbohydrate\] weight ratio with 1600 kcal restriction.

OTHER

Standardized Diet

Participants with GBM treated with radiation and temozolomide after surgical debulking treatment. The subjects will be taken standard diet in a 1:1 ratio. Diet will be started at the time of initiation of radiation treatment.

Trial Locations (1)

20817

MidAtlantic Epilepsy and Sleep Center, Bethesda

All Listed Sponsors
collaborator

Neuroscience Research Foundation, Sewickley,PA

UNKNOWN

lead

Mid-Atlantic Epilepsy and Sleep Center, LLC

OTHER

NCT02302235 - Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study | Biotech Hunter | Biotech Hunter